We are live on
!
Find out more
Saturna Capital Portfolio holdings
AUM
$8.19B
Turnover
10.53%
1-Year Est. Return
42.01%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+42.01%
3 Year Est. Return
+117.49%
5 Year Est. Return
+160.24%
10 Year Est. Return
+637.05%
AUM
$3.83B
AUM Growth
+$91.9M
(+2.5%)
Cap. Flow
-$100M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
22.88%
Holding
417
New
12
Increased
42
Reduced
40
Closed
59
Avg Time Held
1.4
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keysight
KEYS
|
+$15.1M |
| 2 |
Avanos Medical
AVNS
|
+$1.48M |
| 3 |
Fastenal
FAST
|
+$524K |
| 4 |
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
+$482K |
| 5 |
Power Solutions International
PSIX
|
+$432K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$34.1M |
| 2 |
Agilent Technologies
A
|
+$14.8M |
| 3 |
Dentsply Sirona
XRAY
|
+$5.65M |
| 4 |
Dun & Bradstreet
DNB
|
+$4.86M |
| 5 |
Verizon
VZ
|
+$3.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.87% |
| 2 | Industrials | 21.65% |
| 3 | Healthcare | 20.63% |
| 4 | Consumer Staples | 12.84% |
| 5 | Consumer Discretionary | 6.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Clorox
CLX
$10.5B
| $34.8M | 0.91% |
334,165
-20,000
| -6% | -$2M |
2013 Q2
6 quarters
|
|
52
ExxonMobil
XOM
$724B
| $33.3M | 0.87% |
360,409
| – | – |
2013 Q2
6 quarters
|
|
53
General Mills
GIS
$17.7B
| $32.3M | 0.84% |
605,338
| – | – |
2013 Q2
6 quarters
|
|
54
Emcor
EME
$32B
| $32M | 0.84% |
718,587
+247
| +0% | +$10.6K |
2013 Q2
6 quarters
|
|
55
DELISTED
VCA Inc.
WOOF
| $30.7M | 0.8% |
628,900
| – | – |
2013 Q2
6 quarters
|
|
56
Oracle
ORCL
$394B
| $30.5M | 0.8% |
678,650
| – | – |
2013 Q2
6 quarters
|
|
57
Johnson Controls International
JCI
$89.1B
| $29.1M | 0.76% |
575,310
+2,310
| +0.4% | +$113K |
2013 Q2
6 quarters
|
|
58
RTX Corp
RTX
$258B
| $29M | 0.76% |
400,105
| – | – |
2013 Q2
6 quarters
|
|
59
Microchip Technology
MCHP
$41.1B
| $28.9M | 0.75% |
1,280,188
+15,838
| +1% | +$345K |
2013 Q2
6 quarters
|
|
60
DELISTED
Praxair Inc
PX
| $28.7M | 0.75% |
221,825
| – | – |
2013 Q2
6 quarters
|
|
61
GSK
GSK
$99.2B
| $28.4M | 0.74% |
531,640
| – | – |
2013 Q2
6 quarters
|
|
62
L3Harris
LHX
$45.4B
| $28.3M | 0.74% |
394,660
-20,000
| -5% | -$1.38M |
2013 Q2
6 quarters
|
|
63
Stryker
SYK
$113B
| $28.3M | 0.74% |
300,270
| – | – |
2013 Q2
6 quarters
|
|
64
Emerson Electric
EMR
$90.5B
| $27.8M | 0.73% |
450,000
| – | – |
2013 Q2
6 quarters
|
|
65
SAP
SAP
$259B
| $27M | 0.71% |
387,579
-30,000
| -7% | -$2.06M |
2013 Q2
6 quarters
|
|
|
XLNX
66
DELISTED
Xilinx Inc
XLNX
| $26.9M | 0.7% |
622,364
+9,044
| +1% | +$392K |
2013 Q2
6 quarters
|
|
67
Gentex
GNTX
$4.5B
| $25.4M | 0.66% |
1,404,826
| – | – |
2013 Q2
6 quarters
|
|
68
J.M. Smucker
SJM
$13.7B
| $25.3M | 0.66% |
250,340
| – | – |
2013 Q2
6 quarters
|
|
69
AbbVie
ABBV
$504B
| $25.2M | 0.66% |
384,763
| – | – |
2013 Q2
6 quarters
|
|
70
Infosys
INFY
$49B
| $25.2M | 0.66% |
3,200,000
| – | – |
2013 Q2
6 quarters
|
|
71
ConocoPhillips
COP
$173B
| $24.2M | 0.63% |
350,672
| – | – |
2013 Q2
6 quarters
|
|
72
Regal Rexnord
RRX
$10.4B
| $23.6M | 0.62% |
313,600
| – | – |
2013 Q2
6 quarters
|
|
73
McCormick & Company Non-Voting
MKC
$12.4B
| $22.5M | 0.59% |
605,000
| – | – |
2013 Q2
6 quarters
|
|
|
CELG
74
DELISTED
Celgene Corp
CELG
| $22.4M | 0.58% |
200,000
| – | – |
2013 Q2
6 quarters
|
|
75
TotalEnergies
TTE
$200B
| $21.9M | 0.57% |
428,500
+1,400
| +0.3% | +$78.9K |
2013 Q2
6 quarters
|
|
Similar funds
Saturna Capital's Q4 2014 Portfolio in Review
As of Q4 2014, Saturna Capital held 417 positions worth $3.83B, up 2.5% from $3.73B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Saturna Capital's Q4 2014 filing shows 12 new, 42 increased, 40 reduced and 59 closed positions. Its largest new stake was Keysight: 462,173 shares worth $15.6M. The largest sale was Humana, an estimated $34.1M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.
- Saturna Capital's largest Q4 2014 buy was Keysight: 462,173 shares worth $15.6M.
- Saturna Capital added most to Fastenal in Q4 2014, an estimated $524K increase.
- Saturna Capital's biggest Q4 2014 reduction was Humana, cutting an estimated $34.1M.
- Saturna Capital fully exited Dun & Bradstreet in Q4 2014, selling an estimated $4.86M.
- Saturna Capital's ten largest holdings make up 23% of its $3.83B portfolio in Q4 2014.
- Saturna Capital opened 12 new positions and closed 59 in Q4 2014.
- Saturna Capital's portfolio value rose 2.5% quarter-over-quarter to $3.83B.
Based on Saturna Capital's 13F filing for Q4 2014, filed 11 Feb 2015.